Clinical Trial Update: An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating oral and IV palonosetron for prevention of chemotherapy-induced nausea and vomiting; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Palonosetron (palonosetron)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2014-11-17